CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Artrya Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Artrya Ltd
1257 Hay Street, West Perth
Phone: +61 864787816p:+61 864787816 PERTH, WAS  6005  Australia Ticker: AYAAYA
Business Summary
Artrya Limited is a medical technology company. The Company is engaged in development and commercialization of its patented artificial intelligence (AI) platform that detects, diagnoses, and helps address coronary artery. It partners with clinics receiving chest pain patients to deliver new models of cardiovascular care based on AI. Easily integrate plaque features of high prognostic value into the evaluation of coronary artery disease. Its Artrya Salix is a computed tomography coronary angiography (CCTA) image analysis solution that enables physicians with AI to identify and analyze the extent and type of arterial plaque. This solution uses no external reading teams to validate cardiac scan data, allowing physicians direct control of their AI-supported patient scans. Its Artrya Salix assists physicians in the rapid and convenient analysis of cardiac CT scans to screen patients at risk of heart attack.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20266/30/2026Yes----

Industries
SIC Code Description
8071 Medical laboratories
7372 Prepackaged software

General Information
Outstanding Shares: 162,963,615 (As of 6/30/2026)
Shareholders: 1,277
Stock Exchange: ASX


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, September 21, 2026